Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Carroll

Showing results (61-70 of 126) with videos related to

Pageof 13
Sort By:
Cell Reports|June 25, 2020
Targeting Bim via a lncRNA Morrbid Regulates the Survival of Preleukemic and Leukemic CellsZhigang Cai, Fabiola Aguilera, Baskar Ramdas, et al.
Mitochondrion|December 15, 2010
Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial functionMary A Selak, Elise Lyver, Elizabeth Micklow, et al.
Science Translational Medicine|January 27, 2017
CD99 is a therapeutic target on disease stem cells in myeloid malignanciesStephen S Chung, William S Eng, Wenhuo Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2018
Classes of ITD Predict Outcomes in AML Patients Treated with FLT3 InhibitorsGregory W Schwartz, Bryan Manning, Yeqiao Zhou, et al.
The Journal of Biological Chemistry|July 13, 2010
Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolismMargret S Fernandes, Mamatha M Reddy, Nicole J Croteau, et al.
Plos One|April 7, 2016
A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid LeukemiaCaroline E Sloan, Marlise R Luskin, Anne M Boccuti, et al.
Leukemia|January 16, 2024
Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia nicheDing-Wen Chen, Jian-Meng Fan, Julie M Schrey, et al.
Blood|June 12, 2008
mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemiaDavid T Teachey, Cecilia Sheen, Junior Hall, et al.
The Journal of Clinical Investigation|March 20, 2020
Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALLChristian Hurtz, Gerald B Wertheim, Joseph P Loftus, et al.
Blood|March 2, 2017
Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemiaSarah K Tasian, Saad S Kenderian, Feng Shen, et al.
Pageof 13

Showing results (61-70 of 126) with videos related to

Sort By:
Pageof 13
Cell Reports|June 25, 2020
Targeting Bim via a lncRNA Morrbid Regulates the Survival of Preleukemic and Leukemic CellsZhigang Cai, Fabiola Aguilera, Baskar Ramdas, et al.
Mitochondrion|December 15, 2010
Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial functionMary A Selak, Elise Lyver, Elizabeth Micklow, et al.
Science Translational Medicine|January 27, 2017
CD99 is a therapeutic target on disease stem cells in myeloid malignanciesStephen S Chung, William S Eng, Wenhuo Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2018
Classes of ITD Predict Outcomes in AML Patients Treated with FLT3 InhibitorsGregory W Schwartz, Bryan Manning, Yeqiao Zhou, et al.
The Journal of Biological Chemistry|July 13, 2010
Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolismMargret S Fernandes, Mamatha M Reddy, Nicole J Croteau, et al.
Plos One|April 7, 2016
A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid LeukemiaCaroline E Sloan, Marlise R Luskin, Anne M Boccuti, et al.
Leukemia|January 16, 2024
Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia nicheDing-Wen Chen, Jian-Meng Fan, Julie M Schrey, et al.
Blood|June 12, 2008
mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemiaDavid T Teachey, Cecilia Sheen, Junior Hall, et al.
The Journal of Clinical Investigation|March 20, 2020
Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALLChristian Hurtz, Gerald B Wertheim, Joseph P Loftus, et al.
Blood|March 2, 2017
Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemiaSarah K Tasian, Saad S Kenderian, Feng Shen, et al.
Pageof 13